Patents by Inventor Qingnan ZHAO

Qingnan ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatment
    Patent number: 11512141
    Abstract: Provided herein are anti-FGL2 monoclonal antibodies. Further provided herein are methods to reverse suppressive immune mechanisms, such as for the treatment of cancer or infectious diseases.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: November 29, 2022
    Assignee: Board of Regents, The University of Texas System
    Inventors: Shulin Li, Jun Yan, Jiemiao Hu, Xueqing Xia, Qingnan Zhao
  • FGL2 MONOCLONAL ANTIBODIES AND THEIR USE IN TREATING MALIGNANT TUMORS
    Publication number: 20200055955
    Abstract: Provided herein are anti-FGL2 monoclonal antibodies. Further provided herein are methods to reverse suppressive immune mechanisms, such as for the treatment of cancer or infectious diseases.
    Type: Application
    Filed: May 7, 2018
    Publication date: February 20, 2020
    Applicant: Board of Regents, The University of Texas System
    Inventors: Shulin LI, Jun YAN, Jiemiao HU, Xueqing XIA, Qingnan ZHAO